136 related articles for article (PubMed ID: 10872327)
1. Latent and lytic cycle promoters of Epstein-Barr virus.
Farrell PJ; Bankier A; Séguin C; Deininger P; Barrell BG
EMBO J; 1983; 2(8):1331-8. PubMed ID: 10872327
[TBL] [Abstract][Full Text] [Related]
2. DNA sequence and transcription of the BamHI fragment B region of B95-8 Epstein-Barr virus.
Séguin C; Farrell PJ; Barrell BG
Mol Biol Med; 1983 Oct; 1(3):369-92. PubMed ID: 6094953
[TBL] [Abstract][Full Text] [Related]
3. Homologous upstream sequences near Epstein-Barr virus promoters.
Farrell PJ; Deininger PL; Bankier A; Barrell B
Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1565-9. PubMed ID: 6300857
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
5. Transcription and DNA sequence of the BamHI L fragment of B95-8 Epstein-Barr virus.
Biggin M; Farrell PJ; Barrell BG
EMBO J; 1984 May; 3(5):1083-90. PubMed ID: 6203743
[TBL] [Abstract][Full Text] [Related]
6. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1.
Flemington E; Speck SH
J Virol; 1990 Mar; 64(3):1217-26. PubMed ID: 2154605
[TBL] [Abstract][Full Text] [Related]
7. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Baer R; Bankier AT; Biggin MD; Deininger PL; Farrell PJ; Gibson TJ; Hatfull G; Hudson GS; Satchwell SC; Séguin C
Nature; 1984 Jul 19-25; 310(5974):207-11. PubMed ID: 6087149
[TBL] [Abstract][Full Text] [Related]
8. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections.
Chen X; Schmidt MC; Goins WF; Glorioso JC
J Virol; 1995 Dec; 69(12):7899-908. PubMed ID: 7494302
[TBL] [Abstract][Full Text] [Related]
9. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
Zalani S; Holley-Guthrie E; Kenney S
J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
[TBL] [Abstract][Full Text] [Related]
10. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
[TBL] [Abstract][Full Text] [Related]
11. Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript.
Jeang KT; Hayward SD
J Virol; 1983 Oct; 48(1):135-48. PubMed ID: 6310141
[TBL] [Abstract][Full Text] [Related]
12. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
[TBL] [Abstract][Full Text] [Related]
13. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
Countryman JK; Gradoville L; Miller G
J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
15. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
Flemington EK; Lytle JP; Cayrol C; Borras AM; Speck SH
Mol Cell Biol; 1994 May; 14(5):3041-52. PubMed ID: 8164660
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of the BZLF1 promoter of Epstein-Barr virus.
Montalvo EA; Shi Y; Shenk TE; Levine AJ
J Virol; 1991 Jul; 65(7):3647-55. PubMed ID: 1645787
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Epstein-Barr virus DNA polymerase gene.
Furnari FB; Adams MD; Pagano JS
J Virol; 1992 May; 66(5):2837-45. PubMed ID: 1313904
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ; Steven N; Young LS; Rickinson AB
J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
[TBL] [Abstract][Full Text] [Related]
19. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8.
Hudson GS; Farrell PJ; Barrell BG
J Virol; 1985 Feb; 53(2):528-35. PubMed ID: 2982035
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
